ALZN icon

Alzamend Neuro
ALZN

8 hedge funds and large institutions have $59.8K invested in Alzamend Neuro in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$5.32K
2
+$4K
3
+$9

Top Sellers

1
-$35.5K
2
-$17.4K
3
-$15K
4
UBS Group
UBS Group
Switzerland
-$951
5
Citigroup
Citigroup
New York
-$631
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
1
Geode Capital Management
Massachusetts
$37.1K
Truist Financial
2
Truist Financial
North Carolina
$14.7K
Barclays
3
Barclays
United Kingdom
$4K
BlackRock
4
BlackRock
New York
$3.77K
Bank of America
5
Bank of America
North Carolina
$139
AWM
6
Activest Wealth Management
Florida
$19
HIA
7
Harbor Investment Advisory
Maryland
$19
SS
8
SBI Securities
Japan
$17
CSB
9
City State Bank
Iowa
$4
PA
10
Parallel Advisors
California
$3
Morgan Stanley
11
Morgan Stanley
New York
$3
Citadel Advisors
12
Citadel Advisors
Florida
–
Renaissance Technologies
13
Renaissance Technologies
New York
–
VF
14
Virtu Financial
New York
–
UBS Group
15
UBS Group
Switzerland
–
Citigroup
16
Citigroup
New York
–
TRCT
17
Tower Research Capital (TRC)
New York
–
Osaic Holdings
18
Osaic Holdings
Arizona
–